Insights Imaging. 2010 Jan;1(1):30-34. doi: 10.1007/s13244-009-0001-3. Epub 2010 Jan 28.
Multimodality imaging represents an area of rapid growth with important professional implications for both radiologists and nuclear medicine physicians throughout Europe. As a preliminary step for future action aimed at improving the quality and accessibility of PET-SPECT/CT multimodality imaging practice in Europe, the European Society of Radiology (ESR) and the European Association of Nuclear Medicine (EANM) performed a survey among the individual memberships of both societies to obtain information on the status of multimodality imaging in their facilities and their future visions on training for combined modalities. METHODS: A questionnaire was forwarded to all individual members of ESR and EANM. The main subject matter of the questionnaire related to: (1) study performance, current procedures and current equipment, including its supervisory personnel at respondents' individual facilities, and (2) vision of future practice, performance and the potential for combined interdisciplinary viewing and training for future professionals. RESULTS: The reporting and the billing procedures of multimodality imaging studies are very heterogeneous in European countries. The majority of the members of both societies believe that the proportion of PET/CT conducted as a full diagnostic CT with contrast enhancement will increase over time. As expected, 18F-FDG is the most used PET tracer for clinical applications. The large majority of respondents were in favour of an interdisciplinary training programme, being developed on a European level together by ESR and EANM and the respective sections of the European Union of Medical Specialists. CONCLUSION: The results of this survey show that there is wide heterogeneity in the current practice of multimodality imaging in Europe. This situation may limit the full potential and integration of multimodality imaging within the clinical arena. There is a strong desire within both specialties for the development of interdisciplinary training to address some of these issues.
多模态成像领域发展迅速，对欧洲各地的放射科医生和核医学医生都具有重要的专业意义。作为旨在提高欧洲PET-SPECT/CT多模态成像实践质量和可及性的未来行动的初步步骤，欧洲放射学会（ESR）和欧洲核医学协会（EANM）对两个协会的个人会员进行了一项调查，以获取有关其机构中多模态成像现状以及他们对联合模态培训的未来愿景的信息。
向ESR和EANM的所有个人会员发送了一份问卷。问卷的主要主题涉及：（1）研究开展情况、当前程序和当前设备，包括受访者个人机构中的监督人员，以及（2）对未来实践、开展情况以及未来专业人员联合跨学科会诊和培训潜力的愿景。
欧洲各国多模态成像研究的报告和计费程序差异很大。两个协会的大多数成员认为，随着时间的推移，作为增强对比剂的完整诊断CT进行的PET/CT比例将会增加。不出所料，18F-FDG是临床应用中最常用的PET示踪剂。绝大多数受访者赞成由ESR、EANM以及欧洲医学专家联盟各分会在欧洲层面共同制定一项跨学科培训计划。
本次调查结果表明，欧洲目前多模态成像实践存在广泛的异质性。这种情况可能会限制多模态成像在临床领域的全部潜力和整合。两个专业领域都强烈希望开展跨学科培训以解决其中一些问题。
